pfizer glp 1 news cofepris glp-1 🚀Could monthly be the next major advance in obesity treatment? By $7.3 Billion GLP-1 Deal. Pfizers

This phenomenon is particularly pronounced during the first 48 weeks of therapy when gastrointestinal side effects are most intense

In the CY 2025 PFS final rule (89 FR 98448 through 98451), we selected the mean as the methodology for determining the performance threshold for the CY 2025 performance period/2027 MIPS payment year through CY 2027 performance period/2029 MIPS payment year

And tirzepatide, originally developed for diabetes and weight management, turns out to be a powerful cardiovascular protector

Stones larger than 10 mm or that do not respond to conservative treatment may be treated with lithotripsy, ureteroscopy, or rarely, open surgery (Antonelli 2015)